Ver mas grande
BCL2L1 antibody
FT-FNab00843
Producto nuevo
100 µg
Comprando este producto generará 2 Biopuntos. Su cesta contiene un total 2 Biopuntos puede ser convertido en un Biobonos Descuento 8.00EUR.
Hoja técnica
| Size | 100µg |
| Storage Conditions | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| Applications | ELISA, WB, IHC, IF |
| Target | BCL2L1 |
| Research Area | Neuroscience, Cancer, Immunology, Cardiovascular |
| Form | liquid |
| Recomended Dilution | WB: 1:2000-1:20000 |
| Type Clonality | monoclonal |
| Immunogen | BCL2-like 1 |
| Minimum Purity | ≥95% as determined by SDS-PAGE |
| Synonyms | Bcl-2-like protein 1 (Bcl2-L-1)|Apoptosis regulator Bcl-X|BCL2L1|BCL2L|BCLX |
| Host | Mouse |
| UniProt ID | Q07817 |
| Gene ID | 598 |
| Purification | Protein A+G purification |
| Clone Number | 2A9 |
| Iso type | IgG2a |
| Reactivity | Human |
| Observed MW | 35 kDa |
| Background | Potent inhibitor of cell death. Inhibits activation of caspases. Appears to regulate cell death by blocking the voltage-dependent anion channel(VDAC) by binding to it and preventing the release of the caspase activator, CYC1, from the mitochondrial membra |
Más información
BCL2L1 antibody